Screener
Neurocrine Biosciences NBIX Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on the most recent quarter.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's price / earnings?
- Neurocrine Biosciences (NBIX) reported price / earnings of 19.8× in Q1 2026.
- How has Neurocrine Biosciences's price / earnings changed year-over-year?
- Neurocrine Biosciences's price / earnings decreased by 45.2% year-over-year, from 36.1× to 19.8×.
- What is the long-term trend for Neurocrine Biosciences's price / earnings?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's price / earnings has grown at a 5.8% compound annual growth rate (CAGR), from 22.3× to 29.5×.
- What does price / earnings mean?
- Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.
Ask your AI about Neurocrine Biosciences's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude